plicamycin has been researched along with Angiogenesis, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guan, X; Jia, Z; Li, Q; Wang, L; Wei, D; Xie, K; Yao, J; Zhang, J | 1 |
| Jia, Z; Le, X; Li, Q; Wang, L; Wei, D; Xie, K; Yao, J; Yuan, P; Zhang, J | 1 |
2 other study(ies) available for plicamycin and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Targeted inhibition of Sp1-mediated transcription for antiangiogenic therapy of metastatic human gastric cancer in orthotopic nude mouse models.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Cell Line, Tumor; Disease Models, Animal; Drug Synergism; Female; Humans; Mice; Mice, Nude; Neoplasm Metastasis; Neovascularization, Pathologic; Plicamycin; Sp1 Transcription Factor; Stomach Neoplasms; Transcription, Genetic; Vascular Endothelial Growth Factor A | 2008 |
Molecular basis of the synergistic antiangiogenic activity of bevacizumab and mithramycin A.
Topics: Adenocarcinoma; Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Cell Line, Tumor; Drug Synergism; Female; Gene Expression; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Pancreatic Neoplasms; Plicamycin; Promoter Regions, Genetic; Sp1 Transcription Factor; Up-Regulation; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2007 |